Key result
Impaired global hyperaemic myocardial blood flow was the only independent predictor of ventricular arrhythmia inducibility (OR 0.78 per 0.1 mL/min/g increase) in patients with ischaemic left ventricular dysfunction.
Why the study?
Does non-invasive imaging of myocardial perfusion, sympathetic denervation, and scar size predict ventricular arrhythmia inducibility in patients with ischaemic left ventricular dysfunction?
Observational (n=52)
Single-blind
No
Does non-invasive imaging of myocardial perfusion, sympathetic denervation, and scar size predict ventricular arrhythmia inducibility in patients with ischaemic left ventricular dysfunction?
Odds Ratio: 0.78 (95% CI 0.65–0.94)
Absolute Event Rate: 1.36% vs 1.71%
p-value: p=0.007
Global impaired hyperemic myocardial blood flow assessed by PET is an independent predictor of ventricular arrhythmia inducibility in patients with ischemic cardiomyopathy, outperforming scar size and sympathetic denervation.
May inform PET-based arrhythmia risk stratification in ischemic cardiomyopathy; leaves open prospective validation before practice change.
OBJECTIVE: Non-invasive imaging of myocardial perfusion, sympathetic denervation and scar size contribute to enhanced risk prediction of ventricular arrhythmias (VA). Some of these imaging parameters, however, may be intertwined as they are based on similar pathophysiology. The aim of this study was to assess the predictive role of myocardial perfusion, sympathetic denervation and scar size on the inducibility of VA in patients with ischaemic cardiomyopathy in a head-to-head fashion. METHODS: 52 patients with ischaemic heart disease and left ventricular ejection fraction (LVEF) ≤35%, referred for primary prevention implantable cardioverter-defibrillator (ICD) implantation, were included. Late gadolinium-enhanced cardiovascular MRI was performed to assess LV volumes, function and scar size. Using [(15)O]H2O and [(11)C]hydroxyephedrine positron emission tomography, both resting and hyperaemic myocardial blood flow (MBF), and sympathetic innervation were assessed. After ICD implantation, an electrophysiological study (EPS) was performed and was considered positive in case of sustained VA. RESULTS: Patients with a positive EPS (n=25) showed more severely impaired global hyperaemic MBF (p=0.003), larger sympathetic denervation size (p=0.048) and tended to have larger scar size (p=0.07) and perfusion defect size (p=0.06) compared with EPS-negative patients (n=27). No differences were observed in LV volumes, LVEF and innervation-perfusion mismatch size. Multivariable analysis revealed that impaired hyperaemic MBF was the single best independent predictor for VA inducibility (OR 0.78, 95% CI 0.65 to 0.94, p=0.007). A combination of risk markers did not yield incremental predictive value over hyperaemic MBF alone. CONCLUSIONS: Of all previously validated approaches to evaluate the arrhythmic substrate, global impaired hyperaemic MBF was the only independent predictor of VA inducibility. Moreover, a combined approach of different imaging variables did not have incremental value.
No takes yet. Share an insight, caveat, or question.
Rijnierse et al. (2016) conducted an observational in Ischaemic left ventricular dysfunction (n=52). Hyperaemic myocardial blood flow (MBF) vs. Unexposed/reference group was evaluated on Ventricular arrhythmia inducibility during electrophysiological study (OR 0.78, 95% CI 0.65 to 0.94, p=0.007). Impaired global hyperaemic myocardial blood flow was the only independent predictor of ventricular arrhythmia inducibility (OR 0.78 per 0.1 mL/min/g increase) in patients with ischaemic left ventricular dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: